Listed
Stock Code: 308430
| Company Name | 주식회사 셀비온 |
| English Name | Cellbion Co., Ltd |
| Business Reg. No. | 2148863223 |
| CEO | 김권 |
| Address | 서울특별시 종로구 대학로 103 서울대학교 암연구소 6층 |
| Industry | 합성의약품 및 기타 완제 의약품 제조업 |
| Industry Code | 212 |
| Main Products | 셀비온 메브로페닌주 |
| Established | 20100721 |
| Phone | 02-743-3311 |
| Website | cellbion.co.kr |
| Regular Employees | 58persons |
| Corp. Reg. No. | 1101114398180 |
Venture Certified
| 벤처투자유형 | 2015-06-02 ~ 2017-06-01 | 20150300183 | 2015-06-02 |
| 벤처투자유형 | 2017-06-02 ~ 2019-06-01 | 20170300256 | 2015-06-02 |
| 벤처투자유형 | 2019-06-02 ~ 2021-06-01 | 20190300356 | 2015-06-02 |
| 연구개발유형 | 2021-06-02 ~ 2024-06-01 | 20210527020026 | 2015-06-02 |
| 연구개발유형 | 2024-06-02 ~ 2027-06-01 | 20240429020013 | 2015-06-02 |
Revenue CAGR +14.0%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 23B | 15B | 18B |
| Operating Profit | -71B | -50B | -53B |
| Net Profit | -73B | -36B | -64B |
| Total Assets | 344B | 113B | 100B |
| Total Liabilities | 48B | 38B | 73B |
| Total Equity | 296B | 75B | 27B |
Operating Loss: Op. profit -71B
3 Consecutive Years of Net Loss
▲ 41.6%
▼ 38.0%
▲ 3.2%
▼ 89.7%
▲ 82.5%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 김권 | 사내이사 | 대표이사 (CEO) | - |
| 이성호 | 미등기 | 상무이사 | - |
| 신차균 | 미등기 | 고문 | - |
| 김학도 | 미등기 | 연구소 부소장 | - |
| 송성민 | 미등기 | 이사 | - |
| 박재민 | 사내이사 | CFO | - |
| 정혜주 | 사외이사 | 사외이사 | - |
| 조기제 | 감사 | 감사 | - |
| 이송진 | 미등기 | 연구본부장 (CTO) | - |
| 정재민 | 미등기 | CSO | - |
| 안광일 | 미등기 | 연구소장 | - |
| 마상현 | 미등기 | 개발영업 본부장 | - |
| 정동화 | 미등기 | 이사 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - |
| NPS Subscribers | 51persons |
| CEO | 김권 |
| Est. Avg. Annual Salary | 5,12810K (42710K/mo) |
| Hired (12 mo) | +0persons |
| Left (12 mo) | -0persons |
| Net Change (12 mo) | 0persons |
| NPS Join Date | 2011-01-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "서울특별시 종로구 대학로",
"brno": "214886****",
"cappedWarning": false,
"companyName": "주식회사셀비온",
"estimatedAvgAnnualSalary": 51279552,
"estimatedAvgMonthlySalary": 4273296,
"fetchedAt": "2026-03-05T11:25:08.684Z",
"industryCode": "513320",
"industryName": "화장품 및 화장용품 도매업",
"joinDate": "20110101",
"last12MonthsHired": 0,
"last12MonthsLeft": 0,
"last12MonthsNetChange": 0,
"leaveDate": null,
"monthlyPensionAmount": 20704120,
"monthlyTrend": [
{
"lostSubscribers": 0,
"newSubscribers": 0,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6418957",
"status": "1",
"styleCode": "1",
"subscriberCount": 51,
"turnoverMonths": 1
}{
"address": "서울특별시 종로구",
"ceo_name": "김권",
"certificate": [
{
"cert_number": "20150300183",
"changes": "",
"disclosure_date": "2015-06-02",
"first_cert_date": "2015-06-02",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2015-06-02 ~ 2017-06-01"
},
{
"cert_number": "20170300256",
"changes": "",
"disclosure_date": "2017-05-25",
"first_cert_date": "2015-06-02",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2017-06-02 ~ 2019-06-01"
},
{
"cert_number": "20190300356",
"changes": "",
"disclosure_date": "2019-04-25",
"first_cert_date": "2015-06-02",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2019-06-02 ~ 2021-06-01"
},
{
"cert_number": "20210527020026",
"changes": "",
"disclosure_date": "2021-05-27",
"first_cert_date": "2015-06-02",
"no": "4",
"type": "연구개발유형",
"valid_period": "2021-06-02 ~ 2024-06-01"
},
{
"cert_number": "20240429020013",
"changes": "",
"disclosure_date": "2024-04-29",
"first_cert_date": "2015-06-02",
"no": "5",
"type": "연구개발유형",
"valid_period": "2024-06-02 ~ 2027-06-01"
}
],
"company_name": "주식회사 셀비온",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 4852840000,
"cost_of_sales": 1554988000,
"current_assets": 7563336000,
"current_liabilities": 5276935000,
"gross_profit": 207896000,
"net_income": -6382002000,
"net_income_bs": -6382003000,
"non_current_assets": 2473602000,
"non_current_liabilities": 2021570000,
"non_operating_expenses": 1367054000,
"non_operating_income": 288320000,
"operating_profit": -5303268000,
"revenue": 1762884000,
"sga_expenses": 5511164000,
"total_assets": 10036938000,
"total_equity": 2738433000,
"total_liabilities": 7298505000
}
},
"industry": "합성의약품 및 기타 완제 의약품 제조업",
"investment": [
{
"amount": "4,199,976,000",
"changes": "4,199,976,000",
"date": "2017-12-21"
}
],
"main_products": "셀비온 메브로페닌주",
"phone": "02-743-****",
"years": [
2022
]
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |